Rolling Out7d
FDA takes action against Abbvie for misleading Ubrelvy ad with Serena Williams
The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...
FDA calls out AbbVie over ‘misleading’ commercial featuring Serena Williams
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...
BIG on MSN7d
Drug ad featuring Serena Williams is misleading, says FDA
The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...
Commercial drug manufacturing companies for the pharmaceutical industry
Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. Commercial dose form manufacturing follows API manufacturing to produce the final dosage ...
FierceBiotech4d
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
US FDA staff questions confirmatory trial data for Intercept's liver disease drug
Staff reviewers at the U.S. Food and Drug Administration said on Wednesday a confirmatory trial did not show the ...
Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million
How a South Bay diagnostic test maker, with a fresh $57 million, could win big in the fight against deadly sepsis ...
Maggots, other violations reported at North Carolina drug factory
A drug production facility in Durham run by a Chinese company violated multiple safety regulations, according to the FDA. A ...
drugdeliverybusiness4d
Senseonics wins FDA nod for 365-day implantable CGM
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive ...